I’ve seen firsthand how stigma can block life-saving treatments. Medications for addiction treatment offer hope and healing ...

Central Valley leaders are asking voters to weigh in one of the oldest public policy questions: Which works better, the ...

The US Food and Drug Administration (FDA) has just approved a new drug for the treatment of schizophrenia. Marketed under the ...

September is National Recovery Month. It's dedicated to promoting treatment and recovery from alcohol and drug addiction.

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

The facility will offer inpatient and outpatient services, including long-term stays, detox, individual and group therapy.

RelateXR uses virtual reality to help recovering addicts envision the outcome of active addiction versus long-term recovery.

TxGNN is the first AI model specifically developed to identify drug candidates for rare diseases and conditions with no ...

Nivolumab, an immune checkpoint inhibitor lauded for its groundbreaking approach to cancer treatment, marked its 10th ...

Indigenous addiction treatment centres in Alberta are delaying a program developed for the province because of a lack of ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...